Molecular Cytogenetics in Solid Tumors: Laboratorial Tool for Diagnosis, Prognosis, and Therapy

Molecular Cytogenetics in Solid Tumors: Laboratorial Tool for Diagnosis, Prognosis, and Therapy Marileila Varella-Garcia Oncologist 2003; 8: 45-58 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in imaging and diagnostics and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Explain the basic principles supporting the FISH technology and list examples of methodology variants suitable for analysis in metaphase and interphase cells. Describe at least one advantageous and one limiting factor for the expansion of the applicability of FISH assays to solid tumors. Explain technical strategies for detection of chromosomal translocation in nondividing cells. Illustrate applications of cytogenetic markers to solid malignancies for diagnosis, prognosis, selection of therapy, and monitoring disease recurrence or response to treatment. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Mar. 17, 2005 Most Recent Review: Mar. 17, 2005* Most Recent Update: Mar. 17, 2005 Date Credit Expires: Apr. 12, 2007 Time to Complete: 1 hour Medium: Internet Online